Latest Share Capital News

Steadfast Group Limited has updated its dividend announcement, confirming a fully franked dividend of AUD 0.117 per share and setting the Dividend Reinvestment Plan price at AUD 5.982 with a 2.5% discount.

Mercury NZ Limited confirms the share allotment price for its Dividend Reinvestment Plan and details its upcoming dividend payment scheduled for 30 September 2025.

CTI Logistics has updated its 2025 final dividend details, confirming a fully franked payout and share pricing for its Dividend Reinvestment and Bonus Share Plans.

Following the $75 million sale of its Robe Mesa Iron Ore Project, CZR Resources announces the vesting of nearly 5 million options and performance rights, opening the door to potential share conversions.

EMU NL has announced a non-renounceable entitlement offer to raise approximately $1.83 million to fund exploration at its Georgetown and Badja projects, while facing significant governance challenges ahead of a pivotal shareholder meeting.

Platinum Capital Limited has updated the price for its Dividend Reinvestment Plan (DRP) ahead of its fully franked dividend payment for the six months ending June 2025. The dividend of 3 cents per share will be paid on September 22, with new shares issued under the DRP at a revised price.

Dundee Precious Metals has completed its acquisition of Adriatic Metals through a UK court-sanctioned scheme, leading to Adriatic's delisting and a significant board reshuffle. The deal sets the stage for DPM’s ASX debut with new shares trading from mid-September.

Mantle Minerals has announced a proposed capital return of $0.001 per share, subject to shareholder approval at its upcoming AGM, potentially distributing over $6 million back to investors.

Aurum Resources has inked a deal to acquire a significant stake in Major Star Plus Sarl, expanding its gold exploration footprint around its flagship Boundiali and Napié projects in Côte d'Ivoire. The staged earn-in agreement offers Aurum up to 87% interest in key permits, setting the stage for accelerated exploration and potential resource growth.

Opthea Limited reported a 26% reduction in net loss for FY2025 despite discontinuing its wet AMD drug after failed Phase III trials. The company settled its Development Funding Agreement with investors, securing liquidity and planning a strategic pivot.

EZZ Life Science Holdings Limited reported a slight increase in revenue for the year ended June 2025, while net profit experienced a modest decline. The company also boosted its net tangible assets per share and maintained steady dividend payments.

DTI Group Ltd reported an 11% revenue increase and secured a $4 million Adelaide Metro contract, alongside a $2.69 million capital raise to fuel growth. The company also deepened global partnerships and enhanced its technology platform during FY25.